Cargando…
Combining immunomodulators and antivirals for COVID-19 – Authors' reply
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Author(s). Published by Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172165/ https://www.ncbi.nlm.nih.gov/pubmed/34100005 http://dx.doi.org/10.1016/S2666-5247(21)00115-4 |
| _version_ | 1783702485663219712 |
|---|---|
| author | Almansa, Raquel Tedim, Ana P de la Fuente, Amanda Eiros, Jose María Kelvin, David J Torres, Antoni Bermejo-Martin, Jesus F |
| author_facet | Almansa, Raquel Tedim, Ana P de la Fuente, Amanda Eiros, Jose María Kelvin, David J Torres, Antoni Bermejo-Martin, Jesus F |
| author_sort | Almansa, Raquel |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8172165 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | The Author(s). Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81721652021-06-03 Combining immunomodulators and antivirals for COVID-19 – Authors' reply Almansa, Raquel Tedim, Ana P de la Fuente, Amanda Eiros, Jose María Kelvin, David J Torres, Antoni Bermejo-Martin, Jesus F Lancet Microbe Correspondence The Author(s). Published by Elsevier Ltd. 2021-06 2021-06-02 /pmc/articles/PMC8172165/ /pubmed/34100005 http://dx.doi.org/10.1016/S2666-5247(21)00115-4 Text en © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Almansa, Raquel Tedim, Ana P de la Fuente, Amanda Eiros, Jose María Kelvin, David J Torres, Antoni Bermejo-Martin, Jesus F Combining immunomodulators and antivirals for COVID-19 – Authors' reply |
| title | Combining immunomodulators and antivirals for COVID-19 – Authors' reply |
| title_full | Combining immunomodulators and antivirals for COVID-19 – Authors' reply |
| title_fullStr | Combining immunomodulators and antivirals for COVID-19 – Authors' reply |
| title_full_unstemmed | Combining immunomodulators and antivirals for COVID-19 – Authors' reply |
| title_short | Combining immunomodulators and antivirals for COVID-19 – Authors' reply |
| title_sort | combining immunomodulators and antivirals for covid-19 – authors' reply |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172165/ https://www.ncbi.nlm.nih.gov/pubmed/34100005 http://dx.doi.org/10.1016/S2666-5247(21)00115-4 |
| work_keys_str_mv | AT almansaraquel combiningimmunomodulatorsandantiviralsforcovid19authorsreply AT tedimanap combiningimmunomodulatorsandantiviralsforcovid19authorsreply AT delafuenteamanda combiningimmunomodulatorsandantiviralsforcovid19authorsreply AT eirosjosemaria combiningimmunomodulatorsandantiviralsforcovid19authorsreply AT kelvindavidj combiningimmunomodulatorsandantiviralsforcovid19authorsreply AT torresantoni combiningimmunomodulatorsandantiviralsforcovid19authorsreply AT bermejomartinjesusf combiningimmunomodulatorsandantiviralsforcovid19authorsreply |